Bile duct carcinoma
MONDO:0005496A carcinoma that arises from epithelial cells of the bile duct
Also known as: bile duct cancer, bile duct cancer (including cholangiocarcinoma), bile duct carcinoma, carcinoma of bile duct
3350 clinical trials for this condition and its sub-types, 20 tagged with Bile duct carcinoma itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Bile duct carcinoma
-
Extrahepatic bile duct carcinoma 51 trials · 432 incl. sub-types
6 sub-types
- Extrahepatic bile duct adenocarcinoma 2 trials · 409 incl. sub-types Sub-types →
- Carcinoma of the ampulla of vater 29 trials · 65 incl. sub-types Sub-types →
- Distal biliary tract carcinoma 32 trials
- Carcinoma in situ of extrahepatic bile duct 0 trials
- Extrahepatic bile duct leiomyosarcoma 0 trials
- Extrahepatic bile duct squamous cell carcinoma 0 trials Sub-types →
-
Bile duct adenocarcinoma 17 trials · 419 incl. sub-types
1 sub-type
- Extrahepatic bile duct adenocarcinoma 2 trials · 409 incl. sub-types Sub-types →
-
Bile duct carcinoma in situ 0 trials
1 sub-type
-
Squamous cell bile duct carcinoma 0 trials
2 sub-types
Most studied deeper sub-types
-
Immunotherapy drug shows promise in bile duct cancer trial
Disease control CompletedThis Phase 3 trial tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (gemcitabine and cisplatin) helps people with advanced bile duct cancer live longer. The study enrolled 158 Chinese adults with cancer that had spread or could not be removed by…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
Immunotherapy combo shows promise for tough bile duct cancer
Disease control CompletedThis study tested whether adding the immunotherapy drug pembrolizumab to standard chemotherapy (gemcitabine/cisplatin) helps people with advanced bile duct or gallbladder cancer live longer. Over 1,000 participants received either the combination or chemo plus a placebo. The goal…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can acupuncture and ice chips beat chemo nerve damage?
Symptom relief CompletedThis phase 2 trial looked at whether adding acupuncture and acupressure to oral cryotherapy (sucking on ice chips) can reduce nerve pain caused by oxaliplatin chemotherapy in people with gastrointestinal cancers. 78 patients were split into two groups: one got cryotherapy alone, …
Phase 2 • Sponsor: University of Washington • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC